Nov 14, 2022Science and Technology
BIO IP Counsels Committee Conference

Fenwick intellectual property partner Carl Morales will moderate and litigation partner Ryan Johnson will serve on a panel discussing key issues related to “carve outs” and the implications of the GlaxoSmithKline LLC v. Teva Pharms. USA, Inc. series of decisions for induced infringement of method patents.

Be the first to comment.